Metraipolis › archive › dc_2efb69f780ff

Intravitreal aflibercept 8 mg in patients from Japan with neovascular age-related macular degeneration: 48-week subgroup analysis of the PULSAR trial — Europe PMC PMID:41452565

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41452565
DOI: 10.1007/s10384-[numero omesso]-8
License (as archived): solo-consultazione
Archived: 2026-11-07T09:43:50.587Z
SHA-256 of the archived text: 994c56a5050d9174d495294b409b107af9bf3bc69ab58e927d78a3e5c78fcd32
Stable URL of this page: https://metraipolis.com/documento/dc_2efb69f780ff

How to cite

Intravitreal aflibercept 8 mg in patients from Japan with neovascular age-related macular degeneration: 48-week subgroup analysis of the PULSAR trial — Europe PMC PMID:41452565 — Europe PMC (en), https://europepmc.org/article/MED/41452565 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2efb69f780ff (Metraipolis archive dc_2efb69f780ff, sha256 994c56a5050d9174d495294b409b107af9bf3bc69ab58e927d78a3e5c78fcd32)

BibTeX

@misc{dc2efb69f780ff,
  title = {Intravitreal aflibercept 8 mg in patients from Japan with neovascular age-related macular degeneration: 48-week subgroup analysis of the PULSAR trial — Europe PMC PMID:41452565},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41452565},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2efb69f780ff; sha256 994c56a5050d9174d495294b409b107af9bf3bc69ab58e927d78a3e5c78fcd32},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41452565. Agents can read the archived copy with the MCP tool read_document.